Aum Biosciences is an oncology-focused drug development company in Singapore, researching and developing treatments for prevalent cancers in Asia with expert support.

Rootfacts provides high-throughput screening services for drug development, biotechnology, and advanced research. Their tools enable rapid analysis of large chemical libraries for accuracy and speed.

ArisGlobal's LifeSphere® drug development platform integrates a cognitive computing engine to automate core functions, boosting efficiency, ensuring compliance and lowering costs.

Captario's SUM is a SaaS modeling and simulation system that helps pharmaceutical and life sciences teams make informed decisions about projects and portfolios.

Creative Proteomics is the proteomics division of Creative Dynamics Inc, an integrated CRO company providing a full range of drug development services.

Masuu Global assists with drug development, approval, and dossier lifecycle management, to streamline regulatory submissions.

The global Alzheimers drugs market reached US$ 7.7 billion. IMARC Group expects the market to reach US$ 12.4 billion by 2032, exhibiting a 5.3% growth rate (CAGR) during 2024-2032. The rising prevalence of Alzheimers disease, advancements in drug development, and increasing public and private funding for neurodegenerative disease research are major factors driving market growth.

Improve the productivity of oncology drug development at Champions Oncology by leveraging PDX models, humanized mice, syngeneic models and cell lines.

Acutemarketreports.com provides research on the global theranostics market, which combines drug treatment and diagnostics for enhanced drug development.

The next-generation sequencing market is experiencing growth driven by the increasing importance of companion diagnostics in drug development, the rising incidence of cancer, and the growing adoption of targeted therapies.